IT | EN

Information Note on Therapies

The information on this page is for educational purposes only. Ocular microbiota rebalancing is an evolving field of study: the described approaches (dietary, supplementary, or lifestyle) serve as metabolic support and do not in any way replace traditional pharmacological therapies prescribed by a specialist.

Supporting eubiosis (bacterial balance) is not a single medical act, but an integrated clinical pathway for managing ocular dysbiosis that can combine specific hygiene, functional nutrition, and potential microbiome modulation.

Consolidated Clinical Approaches (Primary Evidence)

Eyelid Hygiene & Biofilm Management

Mechanical debridement of the eyelid margin to help reduce bacterial load and support blepharitis treatment.

Omega-3 (EPA/DHA) for Meibomian Glands

Helps modify meibum composition, promoting lipid fluidity and supporting chronic MGD inflammation control.

Low-Dose Tetracyclines (Anti-inflammatory)

Inhibitors of bacterial lipases and MMP-9, evaluated by the physician for support in ocular rosacea.

UV Photoprotection

Use of protective sunglasses to prevent oxidative stress that can damage the tear film.

Complementary Strategies (Systemic Support)

Oral Supplementation (Gut-Eye Axis)

The use of targeted probiotics (e.g., Lactobacillus) is being studied for its potential to modulate the systemic immune response via the Gut-Eye Axis.

Anti-Inflammatory Dietary Regime

A diet rich in fibers and polyphenols supports the production of beneficial anti-inflammatory SCFAs.

Regular Physical Activity

Aerobic exercise can favor the reduction of systemic pro-inflammatory cytokines often associated with dry eye severity.

Future Perspectives (Experimental Research)

Topical Probiotics (Eye Drops)

Direct application of commensal strains to support the surface. Standardized formulations and protocols are currently under clinical study.

Fecal Microbiota Transplant (FMT)

An approach currently under experimental research for severe autoimmune conditions like Sjögren’s Syndrome.

Experimental Phage Therapy

Research on the use of specific viruses (bacteriophages) to target resistant pathogens in the future without altering the healthy microbiome.

Factors to Limit (Risk Management)

Abuse of Topical Antibiotic Therapies

Chronic and indiscriminate use, not validated by a doctor, can reduce protective commensal bacteria, promoting resistance.

Aggressive Ocular Hygiene

Non-ophthalmic or overly aggressive cleansers can strip the essential lipid layer, worsening tear evaporation.

Self-Medication

Prolonged use of OTC drops without a precise diagnostic framing of the ocular surface is not recommended.

Lifestyle & Systemic Factors

🌙 Quality of Night Rest

The "closed-eye microbiome" performs potential reparative and essential immune support functions during sleep.

🧘 Stress Management (Cortisol)

High levels of chronic stress can alter tear composition and reduce resilience against opportunistic pathogens.

Scientific References